Pirozzi Farina Furio, Pischedda Antonella
Andrological Urology Unit, AOU di Sassari, Sassari.
Arch Ital Urol Androl. 2016 Jan 14;87(4):312-6. doi: 10.4081/aiua.2015.4.312.
Treatment-induced sexual dysfunctions (SD) are a recurrent and controversial topic in recent literature on the adverse events related to the use of 5-alpha-reductase inhibitors (5ARIs) (1, 2). In order to deal adequately with the various aspects of this topic, it is necessary to first cover some of the steps that allow a better definition and understanding of the subject.
治疗引起的性功能障碍（SD）是近期有关使用5α-还原酶抑制剂（5ARIs）相关不良事件的文献中反复出现且颇具争议的话题（1, 2）。为了充分探讨该话题的各个方面，有必要首先介绍一些有助于更好地定义和理解该主题的步骤。
